HYFT — MindWalk Holdings Corp.
MindWalk Holdings Corp. functions as an innovative bio-native artificial intelligence firm. Its core mission involves leveraging the synergy of AI, comprehensive multi-omics data, and sophisticated laboratory investigations to accelerate the identification and advancement of biological therapeutics. Utilizing its proprietary LensAI platform and HYFT technology, the company forges partnerships with pharmaceutical and biotechnology enterprises. These collaborations are designed to diminish the inherent risks associated with drug development and to unlock new possibilities for treatments. Founded in 1983, the company adopted its current name, MindWalk Holdings Corp., in September 2025, having previously been known as ImmunoPrecise Antibodies Ltd. Its corporate headquarters are located in Austin, Texas.
Company profile
- Sector: Healthcare
- Industry: Biotechnology
- Country: US
- Exchange: NASDAQ Global Market
- Employees: 102
- Website: https://www.mindwalkai.com
Latest SEC filings for HYFT
- 6-K — 2026-10-22
- 6-K — 2026-10-21
- 6-K — 2026-10-14
- 6-K — 2026-10-06
- 6-K — 2026-10-01
- 6-K — 2026-09-21
- 6-K — 2026-09-21
- 6-K — 2026-09-14
- 6-K — 2026-09-14
- 6-K — 2026-09-14
Latest HYFT news
- — MindWalk Holdings Corp. Strengthens Boston-Based Development Leadership as Pipeline Advances Toward Preclinical Efficacy Studies (businesswire.com)
- — MindWalk (NASDAQ:HYFT) & Fortrea (NASDAQ:FTRE) Head to Head Contrast
- — MindWalk (NASDAQ: HYFT): Enterprise AI Has Found Its Ontology Layer. Biology Needs One Grounded in Biological Function
- — MindWalk (NASDAQ: HYFT): Enterprise AI Has Found Its Ontology Layer. Biology Needs One Grounded in Biological Function (businesswire.com)
- — MindWalk Appoints Kim Remizowski to Board of Directors as Independent Director (businesswire.com)
Educational tool only — not investment advice.